Upload
changezkn
View
530
Download
1
Embed Size (px)
DESCRIPTION
Citation preview
Pulmonary Function Testing in Cystic Fibrosis
Ramachandra R. Sista, MD
Division of Pulmonary & Critical Care Medicine
Stanford University
Cystic Fibrosis – Multisystem disorder
CFTR [Ion Channel]
‘Mutations’
• Defective epithelial salt and fluid transport
• 1 in 2-3K live births in US
Cystic Fibrosis - Airways
Respiratory Tract/Sinus disease
• Chronic airway Inflammation
• Colonization by bacteria
• Rhinosinusitis
• Nasal polyps
• Bronchitis/bronchiectasis
• Hemoptysis
• Productive cough
• Copious sputum production/secretions
• Lung hyperinflation
• PFT evidence for obstructive ventilatory limitation
CF – Airways
Cystic Fibrosis – Lung Function
Respiratory Pump
Thorax
Diaphragm
Abdomen Abdomen
Airways [Trachobronchial tree]
Gas Exchange [Functional units]
Pulmonary Function Testing [PFT]
• Spirometry (Flow Volume Loop) ± BDR
• Lung volumes
• Diffusion capacity (DLCO)
Spirometry
Simple, reproducible and office-based
• How much of air can you move?
- in & out - [vital capacity]
• How fast can you move?
- in & out - [flow / time]
• Based on these two
- FVC and FEV1
Spirometry
• Monitoring of spirometry – simple and quick
• Early recognition and quick intervention for
pulmonary decline / acute exacerbation
• Minimize loss of lung function
Impact of Respiratory Pathogens
• Staph (MRSA, MSSA)
• Pseudomonas (mucoid, non-mucoid, MDR)
• Haemophilus influenza
• Stenotrophamonas maltophilia
• Burkholderia cepacia
• Achromobacter xylocans
• Non-tuberculous mycobacteria [NTM – eg. MAC]
• Aspergillus species [ABPA]
Impact of Respiratory Pathogens
Impact of Airway therapies
Pulmonary therapies
• Antibiotics (PO, IV, IH)
• Macrolide therapy (anti-inflammatory/neutrophil)
• Bronchodilators
• Treatment of ABPA
• DNAase (Dornase, Pulmozyme)
• Hypertonic saline
• N-acetylcysteine
• Chest physiotherapy
• Exercise
Hypertonic saline
Anti Inflammatory Agents
CFRD, Nutrition and Lung function
• Very important part of successful CF management
• Aggressive management of CFRD
• Neutrophil dysfunction
• Associated with accelerated loss of lung function
• Increased mortality risk
Nutrition and BMI
FEV1 percent is positively correlated with BMI percentile for patients 20 to 40 years of age (correlation = 0.92, p < 0.0001)
CFRD – Glucose Control – FEV1
Semin Respir Crit Care Med 2007
Cystic Fibrosis - Cornerstones
• Airway clearance
• Dornase alfa (2.5 mg nebulized daily)
• Nebulized antibiotics
• Oral azithromycin
• Inhaled hypertonic saline [7% 2-4 times per day]
• Aggressive antibiotic therapy for exacerbations
• Nutritional support (high-caloric, high-salt diet)
• Replacement of fat-soluble vitamins [A, D, E, K]
• Exercise
Cystic Fibrosis - Cornerstones
• Airway clearance
• Dornase alfa (2.5 mg nebulized daily)
• Nebulized antibiotics
• Oral azithromycin
• Inhaled hypertonic saline [7% 2-4 times per day]
• Aggressive antibiotic therapy for exacerbations
• Nutritional support (high-caloric, high-salt diet)
• Replacement of fat-soluble vitamins [A, D, E, K]
• Exercise
Acknowledgement
David Weill, MD Pediatric Pulmonologists Gundeep Dhillon, MDPaul Mohabir, MD
Kathy GesleyNicole Eden
Lara Freet
Lesley Seeger
CF Clinical Research Team